CGNH Share Price Performance
Recent CGNH News & Updates
No updates
CardioGenics Holdings Inc Key Details
Last Reported Earnings
Jan 31, 2016
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
CardioGenics Holdings Inc Competitors
About CGNH
- Founded
- 1997
- Employees
- n/a
- CEO
- WebsiteView website
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.
Canadian Market Performance
- 7 Days: -1.8%
- 3 Months: 7.8%
- 1 Year: 18.5%
- Year to Date: 8.6%
Over the last 7 days, the market has dropped 1.8%, driven by pullbacks in every sector, especially the Financials sector. In contrast to the last week, the market is actually up 19% over the past year. Earnings are forecast to grow by 12% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading